Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

GPhC says details on struck off pharmacists should be shared across Europe

Fitness-to-practise information should be shared between European pharmacy regulators, with alerts triggered whenever pharmacists are suspended or have conditions imposed on their practice, the General Pharmaceutical Council (GPhC) has said.

This would help to protect patients by reducing the risk of a pharmacist being suspended from practice in one member state but continuing to work in another, the GPhC said.

The comments came as GPhC chief executive and registrar Duncan Rudkin gave oral evidence to a House of Lords subcommittee in response to an EU review of the mobility of healthcare professionals.

Key points raised by Mr Rudkin included the need to establish a duty on European regulators to share fitness-to-practise information and the need for clearer rules about when regulators could test pharmacists' language competencies.

The GPhC also called for all those wishing to join the English pharmacy register following to a break from practise to be tested on "return to practise" requirements, wherever they qualified.

In a written response to the House of Lords subcommittee, the GPhC stressed: "If fitness-to-practise information is not shared efficiently and effectively, a professional could be erased or suspended in one jurisdiction while continuing to practise in another – such a situation is a serious risk to patient safety."

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD014220

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel